Good product, some good people initially.
Good marketing ,R&D in place in the instance at phase 1
Cons
Terrible leadership - pharma approach to a medical device sale .
Lack of transparency and non reporting of adverse clinical events .
Product usage encouraged off label and beyond its capabilities.
